Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-3
|
pubmed:dateCreated |
1991-5-21
|
pubmed:abstractText |
The reliable detection of fra(X)(q27.3) in prenatal samples is important for providing genetic counseling. We have identified 5 new cases of prenatal fragile X [fra(X)] detection in 3 chorionic villus sample (CVS) and 2 amniotic fluid (AF) cell cultures. In 4 of the 5 cases, either excess thymidine (THY) or a combination of THY and 5-fluorodeoxyuridine (FUdR) was clearly superior to FUdR alone as fra(X) inducers. Amniocytes from one case were cultured only in RPMI-1640 and later exposed to FUdR or THY separately. They showed only 2% fra(X) while parallel cultures initiated in Chang medium and incubated in RPMI for at least 7 days (recovery) before fra(X) induction exhibited strikingly increased fra(X) frequencies. Chang medium alone will not allow fra(X) induction in AF (Jenkins EC, Brown WT [1986]: "Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment." New York: Plenum Press, pp 185-204). Now, using CVS cells, we report that only 1% and 0% fra(X) were detected using FUdR or THY in cells cultured in RPMI for 4 days after removal from Chang medium. Cells with 7 days "recovery" in RPMI exhibited increases from 2 to 6%. Therefore, we have found that Chang medium is very helpful when the appropriate recovery time in another medium is allowed before fra(X) induction. Some false negative reports can be attributed to: induction in Chang medium alone; lack of sufficient recovery time after initiating cells in Chang before induction; and unavailability of the excess THY fra(X) induction system.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0148-7299
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
447-52
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1826813-Amniocentesis,
pubmed-meshheading:1826813-Amniotic Fluid,
pubmed-meshheading:1826813-Cells, Cultured,
pubmed-meshheading:1826813-Chorionic Villi,
pubmed-meshheading:1826813-Chorionic Villi Sampling,
pubmed-meshheading:1826813-Culture Media,
pubmed-meshheading:1826813-Evaluation Studies as Topic,
pubmed-meshheading:1826813-False Negative Reactions,
pubmed-meshheading:1826813-Female,
pubmed-meshheading:1826813-Floxuridine,
pubmed-meshheading:1826813-Fragile X Syndrome,
pubmed-meshheading:1826813-Humans,
pubmed-meshheading:1826813-Male,
pubmed-meshheading:1826813-Pregnancy,
pubmed-meshheading:1826813-Thymidine,
pubmed-meshheading:1826813-X Chromosome
|
pubmed:articleTitle |
Improved prenatal detection of fra(X)(q27.3): methods for prevention of false negatives in chorionic villus and amniotic fluid cell cultures.
|
pubmed:affiliation |
Department of Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|